Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.

At diagnosis of a cT3N0M1 adenocarcinoma of the rectum with synchronous inoperable liver metastases, a 59-year-old man was treated with preoperative radiotherapy (5×5 Gy), followed by laparoscopy-assisted anterior resection of the rectum with total mesorectal excision. At the first postoperative evaluation, a new lung metastasis was detected. First-line chemotherapy with folfiri (5-fluorouracil, irinotecan, leucovorin) resulted in transient stabilization of the metastatic liver disease. At progression, oxaliplatin and 5-fluorouracil-folinic acid were administered by intrahepatic arterial infusion, in combination with intravenous cetuximab. A partial radiologic response was obtained, with complete metabolic response on fluorodeoxyglucose positron-emission tomography, and normalization of carcinoembryonic antigen values. The solitary lung metastasis was sequentially treated with radiotherapy and resection. Five years after the initial diagnosis, this patient remains free from progression, with residual cystic remnants of the liver metastases visible on conventional computed tomography imaging, but not enhancing with fluorodeoxyglucose positron-emission tomography.

[1]  C. Compton,et al.  Colon and Rectum , 2012 .

[2]  N. Kemeny,et al.  Role of adjuvant therapy after resection of colorectal cancer liver metastases. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Pearson,et al.  Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer , 2010 .

[4]  S. Mocellin,et al.  Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. , 2009, The Cochrane database of systematic reviews.

[5]  M. Ducreux,et al.  Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  B. Neyns,et al.  Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. , 2008, Anticancer research.

[7]  W. Scheithauer,et al.  Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[9]  S. Mocellin,et al.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Franco Berrino,et al.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. , 2007, The Lancet. Oncology.

[12]  B. Neyns,et al.  Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  B. Neyns,et al.  Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases. , 2006, Anticancer research.

[15]  R. Goldberg,et al.  Systemic therapy for metastatic colorectal cancer: current options, current evidence. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Jürgen Weitz,et al.  Colorectal cancer , 2005, The Lancet.

[17]  A. Patchefsky,et al.  Case report 3 , 1976, Skeletal Radiology.

[18]  D. Kerr,et al.  Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial , 2003, The Lancet.

[19]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.